Biblio Discovery — Demo Discovery Service

11 results for "Shunjun Fu"

Showing 1–11 · 0.53 seconds · RSS

  1. Journal Article

    Intrahepatic Biliary Cystadenoma With Colonic Adenomatous Polyps in a Patient With Chronic Hepatitis B: A Case Report and Literature Review

    Yan Tang; Chenyu Wang; Shunjun Fu et al.

    Frontiers in Medicine, Vol. 8 · 2021 · English · DOAJ Scopus

    Background: Biliary cystadenomas are rare cystic tumors of the bile duct system that are mostly benign but also have the possibility of malignant transformation. Biliary cystadenomas mostly occur in the intrahepatic bile ducts and are more common in middle-aged women. Due to non-specific radiology…

  2. Journal Article

    Resection combined with hyperthermic intraperitoneal chemotherapy in the treatment of spontaneously ruptured hepatocellular carcinoma: a multicenter retrospective study

    Yufeng Li; Yinghui Song; Shuke Fei et al.

    Therapeutic Advances in Medical Oncology, Vol. 18 · 2026 · English · DOAJ Scopus

    Background: Spontaneous tumor rupture is a unique and life-threatening presentation of hepatocellular carcinoma (HCC). The optimal postoperative management of patients with spontaneously ruptured HCC (srHCC) remains controversial. Hyperthermic intraperitoneal chemotherapy (HIPEC) has been proposed…

  3. Journal Article

    Development and validation of a nomogram for predicting early recurrence in patients undergoing different courses of postoperative adjuvant transarterial chemoembolisation

    Hongkun Tan; Yuyan Xu; Cheng Zhang et al.

    BMC Gastroenterology, Vol. 25 No. 1 · 2025 · English · DOAJ Scopus

    Abstract Background Hepatocellular carcinoma (HCC) is associated with a high rate of postoperative recurrence. Postoperative adjuvant transcatheter arterial chemoembolization (PA-TACE) is effective in preventing recurrence. However, the effect of different courses of PA-TACE on tumor prognosis…

  4. Journal Article

    Case report: Primary hepatocellular carcinoma with portal vein tumor thrombus characterized by active tumor immune microenvironment achieving a complete response following treatment of combined immunotherapy

    Kaihang Zhong; Yuyan Xu; Yuan Cheng et al.

    Frontiers in Immunology, Vol. 13 · 2022 · English · DOAJ Scopus

    Portal vein tumor thrombus (PVTT) is a frequent complication in hepatocellular carcinoma (HCC). HCC patients with PVTT have the characteristics of less treatment tolerance and poor prognosis. Immunotherapy, especially combined immunotherapy, has been successfully used in advanced HCC. However…

  5. Journal Article

    RASGEF1B suppresses hepatocellular carcinoma through the ALDH7A1/Betaine/SNAI1 metabolic‒epigenetic axis

    Zeyi Guo; Kunjiang Tan; Zhongzhe Li et al.

    Journal of Translational Medicine, Vol. 24 No. 1 · 2026 · English · DOAJ Scopus

    Abstract Background Metabolic‒epigenetic crosstalk critically orchestrates hepatocellular carcinoma (HCC) pathogenesis. Deciphering the precise mechanism underlying epigenetic remodeling and metabolic reprogramming in HCC may lead to novel treatment paradigms, however, the key mechanisms remain…

  6. Journal Article

    Identification of Tumor Antigens and Immune Subtypes in Hepatocellular Carcinoma From a Multiomics Perspective

    Chunming Wang; Lei Cai; Qingyu Xie et al.

    Cancer Reports, Vol. 8 No. 9 · 2025 · English · DOAJ Scopus

    ABSTRACT Background Immunotherapies including immune checkpoint inhibitors and tumor antigen based vaccines have revolutionized cancer treatment. However, immune signatures of hepatocellular carcinoma (HCC) have not been thoroughly studied from a multiomics perspective. Aims In this study, we aimed…

  7. Journal Article

    A new cell-free therapeutic strategy for liver regeneration: Human placental mesenchymal stem cell-derived extracellular vesicles

    Ting Li; Yu Fu; Zeyi Guo et al.

    Journal of Tissue Engineering, Vol. 13 · 2022 · English · DOAJ Scopus

    Mesenchymal stem cells (MSCs) have potential role in organ regeneration therapy. Previous work indicating that MSCs confer protection against liver disease. Here, we aimed to determine the potential application in liver regeneration of human placenta-derived MSCs extracellular vesicles (hPMSCs-EVs)…

  8. Journal Article

    Efficacy of combined TAE, HAIC, targeted, and immunotherapy in unresectable HCC: a multicenter propensity score matching study

    Cheng Zhang; Yuyan Xu; Lei Cai et al.

    Scientific Reports, Vol. 15 No. 1 · 2025 · English · DOAJ Scopus

    Abstract Hepatocellular carcinoma is a leading cause of cancer-related death, with unresectable HCC (uHCC) presenting considerable clinical challenges; treatment options are limited, warranting the combination of locoregional therapies. We compared the efficacy of transcatheter arterial…

  9. Journal Article

    Plasma-only circulating tumor DNA analysis detects minimal residual disease and predicts early relapse in hepatocellular carcinoma patients undergoing curative resection

    Yuyan Xu; Jianpeng Cai; Kaihang Zhong et al.

    Frontiers in Oncology, Vol. 13 · 2023 · English · DOAJ Scopus

    BackgroundMinimal residual disease (MRD) is considered an essential factor leading to relapse within 2 years (early relapse) after radical surgery, which is challenging to be detected by conventional imaging. Circulating tumor DNA (ctDNA) provides a novel approach for detecting MRD and predicting…

  10. Journal Article

    Donafenib versus sorafenib in triple therapy for unresectable hepatocellular carcinoma: a propensity score-matched multicenter analysis

    Yaohong Wen; Shuyi Zhou; Yuyan Xu et al.

    World Journal of Surgical Oncology, Vol. 23 No. 1 · 2025 · English · DOAJ Scopus

    Abstract Background In recent years, triple therapy (molecular targeted agent + PD-1 inhibitor + transarterial therapy) has emerged as a promising strategy for unresectable hepatocellular carcinoma (uHCC). However, the optimal molecular targeted agent choice within triple therapy remains unclear…

  11. Journal Article

    A N7-methylguanosine modified circular RNA, circIPP2A2, promotes malignant behaviors in hepatocellular carcinoma by serving as a scaffold in modulating the Hornerin/PI3K/AKT/GSK3β axis

    Zeyi Guo; Zhongzhe Li; Jinhao Guo et al.

    Cell Death and Disease, Vol. 15 No. 11 · 2024 · English · DOAJ Scopus

    Abstract Despite the advancements in treatment strategies, the long-term survival of hepatocellular carcinoma (HCC) is still pessimistic. Therefore, understanding the mechanisms of hepatocellular carcinoma may offer substantial benefits for patients. Our previous research has revealed that Hornerin…